101 related articles for article (PubMed ID: 38730656)
1. TENT5C/FAM46C modulation
Resnati M; Pennacchio S; Viviani L; Perini T; Materozzi M; Orfanelli U; Bordini J; Molteni R; Nuvolone M; Da Vià M; Lazzaroni F; Bolli N; Cenci S; Milan E
Haematologica; 2024 Jun; 109(6):1966-1972. PubMed ID: 38385303
[No Abstract] [Full Text] [Related]
2. Dissecting the Puzzling Roles of FAM46C: A Multifaceted Pan-Cancer Tumour Suppressor with Increasing Clinical Relevance.
Lai G; De Grossi F; Catusi I; Pesce E; Manfrini N
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730656
[TBL] [Abstract][Full Text] [Related]
3. Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer.
Han W; Li C; Wang Y; Huo B; Li W; Shi W
Pharmgenomics Pers Med; 2023; 16():1127-1143. PubMed ID: 38152411
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma.
Kwon H; Yun M; Kwon TH; Bang M; Lee J; Lee YS; Ko HY; Chong K
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137388
[TBL] [Abstract][Full Text] [Related]
5. Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies.
Kim Y; Hwang JY; Kim DK; Na K; Lee S; Baek S; Kang SS; Yang SM; Kim MH; Han H; Lee CY; Han YJ; Hong MH; Lee JB; Lim SM; Cho BC; Park Y; Pyo KH
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760631
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-1269a up-regulation fosters the malignant progression of esophageal squamous cell carcinoma via targeting FAM46C.
Ma Y; Xing X; Cheng C; Kong R; Sun L; Zhao F; Zhang D; Li J
Mutat Res; 2023; 827():111832. PubMed ID: 37467675
[TBL] [Abstract][Full Text] [Related]
7. FAM46C Is an Interferon-Stimulated Gene That Inhibits Lentiviral Particle Production by Modulating Autophagy.
Mancino M; Lai G; De Grossi F; Cuomo A; Manganaro L; Butta GM; Ferrari I; Vicenzi E; Poli G; Pesce E; Oliveto S; Biffo S; Manfrini N
Microbiol Spectr; 2023 Aug; 11(4):e0521122. PubMed ID: 37358411
[TBL] [Abstract][Full Text] [Related]
8. The fusiform gyrus exhibits differential gene-gene co-expression in Alzheimer's disease.
Ribeiro-Dos-Santos A; de Brito LM; de Araújo GS
Front Aging Neurosci; 2023; 15():1138336. PubMed ID: 37255536
[TBL] [Abstract][Full Text] [Related]
9. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
[TBL] [Abstract][Full Text] [Related]
10. circRNA_17725 Promotes Macrophage Polarization towards M2 by Targeting FAM46C to Alleviate Arthritis.
Yang C; Ni B; Li C; Sun W; Wang Z; Wang H; Hou X; Yan S; Wang X; Xu D
Mediators Inflamm; 2023; 2023():6818524. PubMed ID: 37035757
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses.
Flietner E; Yu M; Poudel G; Veltri AJ; Zhou Y; Rajagopalan A; Feng Y; Lasho T; Wen Z; Sun Y; Patnaik MM; Callander NS; Asimakopoulos F; Wang D; Zhang J
Oncogene; 2023 May; 42(21):1751-1762. PubMed ID: 37031341
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FAM46/TENT5 activity by BCCIPα adopting a unique fold.
Liu S; Chen H; Yin Y; Lu D; Gao G; Li J; Bai XC; Zhang X
Sci Adv; 2023 Apr; 9(14):eadf5583. PubMed ID: 37018411
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of endothelial remodeling under doxorubicin treatment.
Podyacheva E; Danilchuk M; Toropova Y
Biomed Pharmacother; 2023 Jun; 162():114576. PubMed ID: 36989721
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognosis analyses of the fibronectin type-III domain-containing (FNDC) protein family in human cancers: A Review.
Jiang H; Chu BL; He J; Liu Z; Yang L
Medicine (Baltimore); 2022 Dec; 101(49):e31854. PubMed ID: 36626432
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.
Kang Y; Sundaramoorthy P; Gasparetto C; Feinberg D; Fan S; Long G; Sellars E; Garrett A; Tuchman SA; Reeves BN; Li Z; Liu B; Ogretmen B; Maines L; Ben-Yair VK; Smith C; Plasse T
Ann Hematol; 2023 Feb; 102(2):369-383. PubMed ID: 36460794
[TBL] [Abstract][Full Text] [Related]
16. TENT5 cytoplasmic noncanonical poly(A) polymerases regulate the innate immune response in animals.
Liudkovska V; Krawczyk PS; Brouze A; Gumińska N; Wegierski T; Cysewski D; Mackiewicz Z; Ewbank JJ; Drabikowski K; Mroczek S; Dziembowski A
Sci Adv; 2022 Nov; 8(46):eadd9468. PubMed ID: 36383655
[TBL] [Abstract][Full Text] [Related]
17. Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors.
Xavier CB; Lopes CDH; Awni BM; Campos EF; Alves JPB; Camargo AA; Guardia GDA; Galante PAF; Jardim DL
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358851
[TBL] [Abstract][Full Text] [Related]
18. FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease.
You Y; Liu C; Liu T; Tian M; Wu N; Yu Z; Zhao F; Qi J; Zhu Q
Free Radic Biol Med; 2022 Nov; 193(Pt 2):808-819. PubMed ID: 36336231
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
